Ireland: Difference between revisions
| Line 45: | Line 45: | ||
=== [[hasReport::Compilation:_Cancer_Statistics_Reports_(Ireland)|Compilation: Cancer Statistics Reports]] === | === [[hasReport::Compilation:_Cancer_Statistics_Reports_(Ireland)|Compilation: Cancer Statistics Reports]] === | ||
=== [[hasReport::Report:_EU_Country_Cancer_Profile_2023_(Ireland)|Report: EU Country Cancer Profile 2023]] === | === [[hasReport::Report:_EU_Country_Cancer_Profile_2023_(Ireland)|Report: EU Country Cancer Profile 2023]] === | ||
Revision as of 20:17, 17 May 2024
Go back to Cancer Centers list.
Cancer Centers
Healthcare System
Administrative or Claims Data
Registries
Database: National Cancer Registry
Database: Vital Statistics
Database: National Oncology Drugs Management System
Databases for Clinical Trials, Surveys and Biobanks
Survey: Irish Health Survey 2019
Survey: Healthy Ireland Survey
Clinical Practices Guidelines
Latest Policymaking Initiatives
Compilation: Cancer Statistics Reports
Report: EU Country Cancer Profile 2023
Sponsor, manager or home institution: OECD and European Commission.
Primary purpose: To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan.
Type of information: National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care.
Data level: National level.
Access to information: Access Information [1].
Report: National Cancer Strategy 2017-2026
Sponsor, manager or home institution: Department of Health.
Primary purpose: To implement a comprehensive strategy designed to achieve specific performance indicators, including reducing smoking rates, enhancing cancer awareness, improving early diagnosis and treatment, and ensuring the delivery of high-quality care for cancer patients in Ireland.
Type of information: Report objectives; Performance indicator; Target and target date; Recommendations; Report implementation.
Data level: National level.
Access to information: Access Information [2].
Compilation: ESMO Patient Guides
Sponsor, manager or home institution: European Society for Medical Oncology
Primary purpose: To translate complex medical language into understandable information for patients.
Available guides: Bone Health in Cancer; Cancer Care During the COVID-19 Pandemic; Cancer Pain Management; Immunotherapy Side Effects; Personalized Cancer Medicine; Survivorship; AML; Biliary Tract Cancer; Bladder Cancer; Bone Sarcoma; Breast Cancer; Cervical Cancer; CML; Colorectal Cancer; Endometrial Cancer; Follicular Lymphoma; Glioma; Head and Neck Cancer; Hepatocellular Carcinoma; Multiple Myeloma; Non-Small-Cell Lung Cancer; Oesophageal Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Soft Tissue Sarcoma; Stomach Cancer; Testicular Cancer.
Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.
Access to information: List of guides [3].
Quality of Life and Palliative Care Research
List of Articles: Quality of Life [4] and Palliative Care [5].
